BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17171645)

  • 1. Identification of FAZF as a novel BMP2-induced transcription factor during osteoblastic differentiation.
    Ikeda R; Yoshida K; Inoue I
    J Cell Biochem; 2007 May; 101(1):147-54. PubMed ID: 17171645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1.
    Ikeda R; Yoshida K; Tsukahara S; Sakamoto Y; Tanaka H; Furukawa K; Inoue I
    J Biol Chem; 2005 Mar; 280(9):8523-30. PubMed ID: 15623533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current topics in pharmacological research on bone metabolism: Promyelotic leukemia zinc finger (PLZF) and tumor necrosis factor-alpha-stimulated gene 6 (TSG-6) identified by gene expression analysis play roles in the pathogenesis of ossification of the posterior longitudinal ligament.
    Inoue I; Ikeda R; Tsukahara S
    J Pharmacol Sci; 2006 Mar; 100(3):205-10. PubMed ID: 16547399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
    Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
    Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.
    Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD
    Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
    Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
    Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts.
    Shen ZJ; Nakamoto T; Tsuji K; Nifuji A; Miyazono K; Komori T; Hirai H; Noda M
    J Biol Chem; 2002 Aug; 277(33):29840-6. PubMed ID: 12023967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
    Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
    J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into strand exchange in BTB domain dimers from the crystal structures of FAZF and Miz1.
    Stogios PJ; Cuesta-Seijo JA; Chen L; Pomroy NC; Privé GG
    J Mol Biol; 2010 Jul; 400(5):983-97. PubMed ID: 20493880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.
    Takagi M; Kamiya N; Takahashi T; Ito S; Hasegawa M; Suzuki N; Nakanishi K
    J Mol Histol; 2004 Jan; 35(1):81-90. PubMed ID: 15323353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
    Bae JS; Gutierrez S; Narla R; Pratap J; Devados R; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Javed A
    J Cell Biochem; 2007 Feb; 100(2):434-49. PubMed ID: 16927309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.
    Tou L; Quibria N; Alexander JM
    Mol Cell Endocrinol; 2003 Jul; 205(1-2):121-9. PubMed ID: 12890574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells.
    Tsuji K; Ito Y; Noda M
    Bone; 1998 Feb; 22(2):87-92. PubMed ID: 9477230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells.
    Zhu W; Boachie-Adjei O; Rawlins BA; Frenkel B; Boskey AL; Ivashkiv LB; Blobel CP
    J Biol Chem; 2007 Jun; 282(26):18676-85. PubMed ID: 17439946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
    Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
    Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor BACH1 is recruited to the nucleus by its novel alternative spliced isoform.
    Kanezaki R; Toki T; Yokoyama M; Yomogida K; Sugiyama K; Yamamoto M; Igarashi K; Ito E
    J Biol Chem; 2001 Mar; 276(10):7278-84. PubMed ID: 11069897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein-2 induces expression of murine zinc finger transcription factor ZNF450.
    Edgar AJ; Dover SL; Lodrick MN; McKay IJ; Hughes FJ; Turner W
    J Cell Biochem; 2005 Jan; 94(1):202-15. PubMed ID: 15526281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.
    Li X; Lopez-Guisa JM; Ninan N; Weiner EJ; Rauscher FJ; Marmorstein R
    J Biol Chem; 1997 Oct; 272(43):27324-9. PubMed ID: 9341182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.